HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H104. A total of 1 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $30,000 | -51.6% | 92,115 | +7.0% | 0.00% | – |
Q2 2020 | $62,000 | +138.5% | 86,055 | +5.8% | 0.00% | – |
Q1 2020 | $26,000 | -54.4% | 81,372 | 0.0% | 0.00% | – |
Q4 2019 | $57,000 | +58.3% | 81,372 | +50.2% | 0.00% | – |
Q3 2019 | $36,000 | -60.0% | 54,178 | 0.0% | 0.00% | – |
Q2 2019 | $90,000 | -33.3% | 54,178 | 0.0% | 0.00% | – |
Q1 2019 | $135,000 | -2.2% | 54,178 | 0.0% | 0.00% | – |
Q4 2018 | $138,000 | -49.6% | 54,178 | 0.0% | 0.00% | – |
Q3 2018 | $274,000 | +52.2% | 54,178 | -2.0% | 0.00% | – |
Q2 2018 | $180,000 | -4.8% | 55,300 | +5.8% | 0.00% | – |
Q1 2018 | $189,000 | – | 52,258 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sonora Investment Management, LLC | 466 | $2,000 | 0.00% |